help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2007-0370
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haugen, F.
Right arrow Articles by Drevon, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haugen, F.
Right arrow Articles by Drevon, C. A.
Endocrinology Vol. 148, No. 11 5478-5486
Copyright © 2007 by The Endocrine Society

Activation of Nuclear Factor-{kappa}B by High Molecular Weight and Globular Adiponectin

Fred Haugen and Christian A. Drevon

Department of Nutrition, Institute of Basic Medical Sciences, Medical Faculty, University of Oslo, 0316 Oslo, Norway

Address all correspondence and requests for reprints to: Fred Haugen, Ph.D., Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1046 Blindern, 0316 Oslo, Norway. E-mail: fred.haugen{at}medisin.uio.no.

Adipose tissue secretes a wide range of hormones named adipokines, and these may play a role in obesity-related inflammation. Adiponectin is an exceptional adipokine because low plasma concentrations are associated with obesity, type 2 diabetes, and cardiovascular diseases. It has been observed that plasma adiponectin concentrations are elevated during inflammatory conditions like preeclampsia and arthritis. Nuclear factor-{kappa}B (NF-{kappa}B) is an essential transcription factor for expression of inflammation-related proteins. We have used U937 cells stably transfected to express luciferase under the control of NF-{kappa}B to examine if adiponectin may modulate NF-{kappa}B activity. Physiological concentrations of native adiponectin induced NF-{kappa}B activity. This effect was relatively strong compared with proinflammatory adipokines like leptin, resistin, and IL-6. The enhanced NF-{kappa}B activity was attributed to the high molecular weight adiponectin isoforms. NF-{kappa}B was not activated by mutated adiponectin that is unable to form high molecular weight complexes. Furthermore, the C-terminal fragment, globular adiponectin, markedly increased NF-{kappa}B reporter activity, cytokine release, and mRNA expression of inflammation marker genes, at higher levels than stimulation with TNF-{alpha} and lipopolysaccharide. NF-{kappa}B activation by globular adiponectin was not affected by antibody inhibition of toll-like receptor 4 or TNF receptors 1 and 2 but was attenuated by inhibitors of p38 MAPK, phosphatidylinositol 3-kinase, and protein kinase C. Analyses of the p65 subunit of NF-{kappa}B in different leukocyte cell lines showed activation of two monocytic cell lines (U937 and THP-1) by native and globular adiponectin. Our results indicate that adiponectin has proinflammatory properties in monocytic cells.




This article has been cited by other articles:


Home page
GutHome page
H. Tilg and A. Kaser
Adiponectin and JNK: metabolic/inflammatory pathways affecting gastrointestinal carcinogenesis
Gut, December 1, 2009; 58(12): 1576 - 1577.
[Full Text] [PDF]


Home page
EndocrinologyHome page
G. A. Williams, Y. Wang, K. E. Callon, M. Watson, J.-m. Lin, J. B. B. Lam, J. L. Costa, A. Orpe, N. Broom, D. Naot, et al.
In Vitro and in Vivo Effects of Adiponectin on Bone
Endocrinology, August 1, 2009; 150(8): 3603 - 3610.
[Abstract] [Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
C. POPA, M. G. NETEA, J. de GRAAF, F. H.J. van den HOOGEN, T. R.D.J. RADSTAKE, H. TOENHAKE-DIJKSTRA, P. L.C.M. van RIEL, J. W.M. van der MEER, A. F.H. STALENHOEF, and P. BARRERA
Circulating Leptin and Adiponectin Concentrations During Tumor Necrosis Factor Blockade in Patients with Active Rheumatoid Arthritis
J Rheumatol, April 1, 2009; 36(4): 724 - 730.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Xu, H. Wang, R. L. C. Hoo, G. Sweeney, Paul. M. Vanhoutte, Y. Wang, D. Wu, W. Chu, G. Qin, and K. S. L. Lam
Selective Elevation of Adiponectin Production by the Natural Compounds Derived from a Medicinal Herb Alleviates Insulin Resistance and Glucose Intolerance in Obese Mice
Endocrinology, February 1, 2009; 150(2): 625 - 633.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Pini, M. E. Gove, J. A. Sennello, J. W. P. M. van Baal, L. Chan, and G. Fantuzzi
Role and Regulation of Adipokines during Zymosan-Induced Peritoneal Inflammation in Mice
Endocrinology, August 1, 2008; 149(8): 4080 - 4085.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. L. Peterlin, G. Alexander, D. Tabby, and E. Reichenberger
Oligomerization state-dependent elevations of adiponectin in chronic daily headache
Neurology, May 13, 2008; 70(20): 1905 - 1911.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society